David J. Heal

7.2k total citations · 1 hit paper
173 papers, 5.8k citations indexed

About

David J. Heal is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David J. Heal has authored 173 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Cellular and Molecular Neuroscience, 64 papers in Molecular Biology and 42 papers in Pharmacology. Recurrent topics in David J. Heal's work include Neurotransmitter Receptor Influence on Behavior (95 papers), Neuroscience and Neuropharmacology Research (46 papers) and Receptor Mechanisms and Signaling (44 papers). David J. Heal is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (95 papers), Neuroscience and Neuropharmacology Research (46 papers) and Receptor Mechanisms and Signaling (44 papers). David J. Heal collaborates with scholars based in United Kingdom, United States and Spain. David J. Heal's co-authors include Sharon L. Smith, Jane Gosden, Sharon C. Cheetham, W. R. Buckett, David Nutt, C.A. Marsden, James M. Elliott, A. David Smith, Guy M. Goodwin and Keith F. Martin and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Biological Psychiatry.

In The Last Decade

David J. Heal

166 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amphetamine, past and present – a pharmacological and clinical perspective

2013 385 citations David J. Heal, Sharon L. Smith et al. Journal of Psychopharmacology profile →

Peers

David J. Heal

CMN

PMH

PHARM

David S. Janowsky United States

Brigitta Bondy Germany

Mark D. Underwood United States

Joanna C. Neill United Kingdom

José N. Nóbrega Canada

Mark J. Millan France

Jeffrey M. Witkin United States

Bryan K. Yamamoto United States

H. Scott Swartzwelder United States

Kenneth W. Perry United States

David S. Janowsky United States

David J. Heal

2.7k ×0.8

CMN

1.7k ×1.0

1.5k ×1.2

PMH

1.2k ×1.0

PHARM

1.1k ×1.3

Citations per year, relative to David J. Heal David J. Heal (= 1×) peers David S. Janowsky

Countries citing papers authored by David J. Heal

Since Specialization

Citations

This map shows the geographic impact of David J. Heal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Heal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Heal more than expected).

Fields of papers citing papers by David J. Heal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Heal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Heal. The network helps show where David J. Heal may publish in the future.

Co-authorship network of co-authors of David J. Heal

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Heal. A scholar is included among the top collaborators of David J. Heal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Heal. David J. Heal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heal, David J., Sharon L. Smith, Jane Gosden, et al.. (2025). Evaluation of the Abuse Potential of the Cholesterol-24-Hydroxylase Inhibitor, Soticlestat, in Drug-Discrimination and Self-Administration Tests. Drug and Alcohol Dependence. 267. 111937–111937.

Heal, David J., Sharon L. Smith, Jane Gosden, et al.. (2025). Assessment of Withdrawal-Induced Physical Dependence in Rats After Administration of the Potent Cholesterol-24-Hydroxylase Inhibitor, Soticlestat. Drug and Alcohol Dependence. 267. 111939–111939.

Heal, David J., Sharon L. Smith, & Jack E. Henningfield. (2025). Psychedelic research – Going global. Journal of Psychopharmacology. 4126448535–4126448535.

Henningfield, Jack E., Marion A. Coe, Roland R. Griffiths, et al.. (2022). Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology. 218. 109220–109220. 25 indexed citations

Gray, Richard A., David J. Heal, David R. Maguire, et al.. (2022). Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence. Journal of Pharmacology and Experimental Therapeutics. 382(1). 54–65. 8 indexed citations

Freeman, Kevin B., David J. Heal, Andrew C. McCreary, & William L. Woolverton. (2012). Assessment of ropinirole as a reinforcer in rhesus monkeys. Drug and Alcohol Dependence. 125(1-2). 173–177. 8 indexed citations

Heal, David J., Jane Gosden, & Sharon L. Smith. (2011). The 5-HT6 Receptor as a Target for Developing Novel Antiobesity Drugs. International review of neurobiology. 96. 73–109. 25 indexed citations

Géranton, Sandrine M., David J. Heal, & S. Clare Stanford. (2004). 5-HT has contrasting effects in the frontal cortex, but not the hypothalamus, on changes in noradrenaline efflux induced by the monoamine releasing-agent, d-amphetamine, and the reuptake inhibitor, BTS 54 354. Neuropharmacology. 46(4). 511–518. 4 indexed citations

Géranton, Sandrine M., David J. Heal, & S. Clare Stanford. (2003). Noradrenaline clearance differs in the frontal cortex and hypothalamus: a dual-probe microdialysis study in freely-moving rats. Neuroscience Letters. 350(3). 157–160. 3 indexed citations

10.

Wortley, Katherine E., Zoë A. Hughes, David J. Heal, & S. Clare Stanford. (1999). Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d‐amphetamine: modulation by α₂‐adrenoceptors. British Journal of Pharmacology. 127(8). 1860–1866. 24 indexed citations

11.

Heal, David J.. (1995). Mediation of mydriasis in conscious rats by central postsynaptic α2-adrenoceptors. Pharmacology Biochemistry and Behavior. 50(2). 219–224. 15 indexed citations

12.

Fulford, Allison, et al.. (1994). Evidence for altered α2-adrenoceptor function following isolation-rearing in the rat. Psychopharmacology. 116(2). 183–190. 28 indexed citations

13.

Luscombe, Graham P., et al.. (1993). Mediation of the antidepressant‐like effect of 8‐OH‐DPAT in mice by postsynaptic 5‐HT_1A receptors. British Journal of Pharmacology. 108(3). 669–677. 73 indexed citations

14.

Cheetham, Sharon C., Jean Viggers, Nigel K.H. Slater, David J. Heal, & W. R. Buckett. (1993). [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments. Neuropharmacology. 32(8). 737–743. 109 indexed citations

15.

Marsden, C.A. & David J. Heal. (1992). Central serotonin receptors and psychotropic drugs. 48 indexed citations

16.

Heal, David J., et al.. (1992). A comparison of various antidepressant drugs demonstrates rapid desensitisation of α2-adrenoceptors exclusively by sibutramine hydrochloride. Psychopharmacology. 107(4). 497–502. 11 indexed citations

17.

Martin, Keith F., et al.. (1992). Opposing roles for 5‐HT_1Band 5‐HT₃receptors in the control of 5‐HT release in rat hippocampusin vivo. British Journal of Pharmacology. 106(1). 139–142. 86 indexed citations

18.

Heal, David J. & C.A. Marsden. (1990). The Pharmacology of noradrenaline in the central nervous system. Oxford University Press eBooks. 125 indexed citations

19.

Heal, David J., et al.. (1989). Clonidine produces mydriasis in conscious mice by activating central α2-adrenoceptors. European Journal of Pharmacology. 170(1-2). 11–18. 14 indexed citations

20.

Heal, David J., et al.. (1989). Antidepressant Treatments, Including Sibutramine Hydrochloride and Electroconvulsive Shock, Decrease β₁ but Not β₂‐Adrenoceptors in Rat Cortex. Journal of Neurochemistry. 53(4). 1019–1025. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact